Past Medical History: # Past Oncologic History: DLBCL stage IVEB on R-[**Hospital1 **] - [**5-/2194**] Developed new back pain - [**7-/2194**] Developed low grade fever of 99s and symptomatic - [**8-/2194**] Developed nightly drenching night sweats - [**2194-8-27**] Seen for above symptoms.
- [**8-29**] and [**2194-9-4**] MRI showed increased signal intensity in the marrow spaces in the spine as well as scattered enhancing lesions in several vertebrae.
- [**2194-9-8**] CT torso without obvious adenopathy, thoracic, abdominal, or pelvic pathology.
Found to have worsening anemia to H/H of 10.7/31.6, low reticulocyte count, new thrombocytosis to 632, elevated ferritin to 2067, rising transaminases to AST/ALT of 86/141 with an alk phos up to 174, an LDH of 588, and normal B12 and folate.
- [**2194-9-8**] Bone marrow biopsy with fibrosis and organizing bone, indeterminate.
- [**2194-9-12**] LDH up to 1664, Ca up to 10.5, ferritin 3805, CRP above assay, more anemic.
Repeat BMBx showed large atypical cells which co-express B-cell marker CD20 along with CD10 and bcl-2 C-MYC negative c/w DLBCL.
- [**2194-9-18**] C1D1 R-da-[**Hospital1 **] (rituximab 375 mg/m2, etoposide 50 mg/m2, doxorubicin 10 mg/m2, vincristine 0.5 mg, cyclophosphamide 750 mg/m2, Prednisone 100 mg) c/b afib w RVR.
- [**2194-10-9**] C2 R-da-[**Hospital1 **] with 20% increase of etoposide, doxorubicin, and cyclophosphamide for good ANC in C1 (rituximab 375 mg/m2, etoposide 60 mg/m2, doxorubicin 12 mg/m2, vincristine 0.5 mg, cyclophosphamide 900 mg/m2, prednisone 100 mg).
Physical Exam: Physical Exam on Admission:  Vitals: BP: 108/89 P:87 R:16 18 O2: 98%RA General: Alert, oriented, no acute distress HEENT: Sclera anicteric, PERRLA, MMM, OP without exudates or lesions, Neck: supple, JVP not elevated, shotty cervical LAD Lungs: Clear to auscultation bilaterally, no wheezes, rales, ronchi CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly GU: no foley Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema, no calf tenderness  Physical Exam on Discharge:  Unchanged from admission  Pertinent Results: Lab Results on Admission: [**2194-10-20**] 11:41PM   PT-12.6 PTT-122.5* INR(PT)-1.1 [**2194-10-20**] 02:48PM   GLUCOSE-101* UREA N-15 CREAT-0.7 SODIUM-136 POTASSIUM-4.3 CHLORIDE-102 TOTAL CO2-27 ANION GAP-11 [**2194-10-20**] 02:48PM   estGFR-Using this [**2194-10-20**] 02:48PM   ALT(SGPT)-118* AST(SGOT)-48* ALK PHOS-102 TOT BILI-0.3 [**2194-10-20**] 02:48PM   LIPASE-34 [**2194-10-20**] 02:48PM   ALBUMIN-3.9 CALCIUM-9.0 PHOSPHATE-4.1 MAGNESIUM-2.1 [**2194-10-20**] 02:48PM   WBC-2.9*# RBC-3.60* HGB-10.0* HCT-29.6* MCV-82 MCH-27.8 MCHC-33.8 RDW-20.0* [**2194-10-20**] 02:48PM   WBC-2.9*# RBC-3.60* HGB-10.0* HCT-29.6* MCV-82 MCH-27.8 MCHC-33.8 RDW-20.0* [**2194-10-20**] 02:48PM   NEUTS-75.8* LYMPHS-16.9* MONOS-1.3* EOS-5.8* BASOS-0.3 [**2194-10-20**] 02:48PM   PLT COUNT-269 [**2194-10-20**] 02:48PM   PT-11.7 PTT-30.4 INR(PT)-1.0  Imaging: [**10-20**] CTA Chest: IMPRESSION: 1.
2 mm right upper lobe pulmonary nodule, also seen on recent prior study of [**2194-9-13**].
The proximal extent of the clot is not well seen on this study and further assessment of thrombus noted as well as vein anatomy can be obtained by MRV or CTV if indicated  [**10-22**] Echo: IMPRESSION: Normal regional and global biventricular systolic function.
[**10-23**] CXR: FINDINGS: In comparison to the prior chest radiograph there is no major change.
Microbiology: Blood cultures: no growth  Lab results on Discharge:  [**2194-10-25**] 01:00AM BLOOD WBC-35.2* RBC-3.01* Hgb-8.6* Hct-25.0* MCV-83 MCH-28.6 MCHC-34.4 RDW-22.4* Plt Ct-175 [**2194-10-25**] 01:00AM BLOOD Neuts-61 Bands-3 Lymphs-5* Monos-3 Eos-3 Baso-0 Atyps-1* Metas-2* Myelos-2* Promyel-2* NRBC-1* Other-18* [**2194-10-25**] 01:00AM BLOOD Hypochr-NORMAL Anisocy-2+ Poiklo-1+ Macrocy-1+ Microcy-2+ Polychr-OCCASIONAL Ovalocy-1+ Tear Dr[**Last Name (STitle) 833**] [**2194-10-25**] 06:30AM BLOOD PT-17.1* PTT-71.0* INR(PT)-1.5* [**2194-10-22**] 04:47AM BLOOD Gran Ct-454* [**2194-10-25**] 01:00AM BLOOD Glucose-111* UreaN-9 Creat-0.8 Na-144 K-3.8 Cl-107 HCO3-26 AnGap-15 [**2194-10-25**] 01:00AM BLOOD ALT-98* AST-59* LD(LDH)-435* AlkPhos-127 TotBili-0.3 [**2194-10-22**] 04:47AM BLOOD CK-MB-2 cTropnT-<0.01 [**2194-10-22**] 12:35PM BLOOD CK-MB-2 cTropnT-<0.01 [**2194-10-22**] 08:45PM BLOOD CK-MB-2 cTropnT-<0.01 [**2194-10-25**] 01:00AM BLOOD Calcium-9.4 Phos-5.4* Mg-1.9 [**2194-10-23**] 04:52PM BLOOD Type-ART pO2-82* pCO2-39 pH-7.44 calTCO2-27 Base XS-1 Intubat-NOT INTUBA [**2194-10-24**] 01:16PM BLOOD Lactate-2.0  Brief Hospital Course: Primary Reason for Hospitalization: Patient is a 56M w/diffuse Bcell lymphoma stage IV who recently completed daEPOCH (D12 on admission) and with recent line associated RUE DVT on fondaparinux who presented with palpatations and dyspnea found to have multiple PEs on CTA.
Echo showed no heart strain and cardiac enzymes showed no elevation.
His EKG was unchanged from baseline.
He was on lepirudin gtt for 2 days while awaiting results of heparin-dependent antibody test which showed no antibody detected.
Admission WBC 2.9 on Neupogen daily.
You were admitted to the hospital with heart palpitations and shortness of breath and you were found to have blood clots that had traveled to your lungs.
